Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BTF is a biotechnology company specializing in the development and manufacture of quantitative biological reference materials and standards for the life sciences sector. The company is best known for its proprietary BioBall technology, which provides precise, small-number microbial samples used for quality control in pharmaceutical, food, and water testing laboratories. Founded in 1999 and headquartered in Sydney, Australia, BTF's products are essential for validating microbiological methods and ensuring regulatory compliance. Following its acquisition by bioMérieux in 2007, BTF's technologies have been integrated into a global portfolio of industrial microbiology solutions, serving major pharmaceutical companies and analytical laboratories worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BTF.